BioPharma Dive - Latest News

Rallybio discontinues lead candidate for rare maternal disease

The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal blood disorder.

Apr 8, 2025 - 16:55
 0
Rallybio discontinues lead candidate for rare maternal disease

The company has decided to switch gears following disappointing data for a monoclonal antibody targeting a rare maternal blood disorder.

Read More

Tags:

Previous Article

Taraji P. Henson Buys Brand From Maesa

Next Article

Trump expected to sign order to allow coal-fired power plants to remain open

Related Posts

CDC vaccine meeting, set to be first since RFK Jr. sworn in, is postponed

CDC vaccine meeting, set to be first since RFK Jr. swor...

Feb 20, 2025  0

Amgen obesity drug on hold; Regeneron sets first dividend

Amgen obesity drug on hold; Regeneron sets first dividend

Feb 9, 2025  0

FDA misses approval deadline for Novavax’s COVID-19 vaccine

FDA misses approval deadline for Novavax’s COVID-19 vac...

Apr 3, 2025  0